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new endosomal protein keeps ESCRT-I 
too wrapped up in itself to be attracted 
to anyone else, Chu et al. reveal on 
page 815. This matchbreaker prevents the 
premature assembly of the machinery that 
forms multivesicular bodies (MVBs).
MVBs are endosomes with internal vesicles. 
The vesicles contain membrane proteins bound 
for fusion with lysosomes or viral particles 
hoping to escape from the cell. Vesicles bud 
internally from the endosomal membrane with 
help from three ESCRT complexes (I, II, and III) 
that are sequentially recruited from the cytosol 
to the endosome. Chu et al. found a new 
component that helps keep this recruitment in 
proper order.
The helper is a small protein, which the 
authors call Mvb12, that binds to ESCRT-I and 
regulates its associations. With Mvb12, most 
ESCRT-I was found in stable cytoplasmic oligo-
mers (probably trimers). Exactly how Mvb12 
stabilizes the oligomers is not clear.
The oligomerization seems to mask 
ESCRT-I’s binding site for ESCRT-II; in the 
absence of Mvb12, ESCRT-I was instead 
locked together with ESCRT-II, both in the 
cytoplasm and on endosomes. Their premature 
joining resulted in inefﬁ   cient sorting into 
MVBs; much of the MVB cargo remained on 
the endosomal surface.
The authors now want to understand 
how Mvb12 release is prompted to allow 
timely ESCRT-II binding. Encountering PI3P 
and ubiquitinated cargo on the endosome 
might release Mvb12, resulting in oligomer 
disassembly and ESCRT-II binding. The ﬁ  nal 
stages of MVB formation, including ESCRT-III 
recruitment, can then follow.
Do-it-yourself insertion
T
he membrane insertion of eukaryotic proteins generally requires the 
assistance of other membrane proteins. But on page 767, Brambillasca 
et al. show that surprisingly long protein stretches get across membranes 
unassisted, as long as their transmembrane domains (TMD) are not too 
hydrophobic. Ancestral membrane proteins may have similarly self-inserted.
The group started with a variant of cytochrome b(5), whose 28-residue 
luminal domain was known to push its way through protein-free liposomes. 
They now fi  nd that b5 can push luminal domains of up to 85 residues through 
liposomes and into the ER of yeast cells lacking the normal translocation 
machinery. Unassisted translocation might also pick up the slack in normal 
eukaryotic cells when ER translocons are congested.
A membrane protein of similar topology, called Syb2, had no such power. 
The authors traced the disparity to the TMD: the lower hydrophobicity of b5’s 
TMD was unexpectedly advantageous for insertion into liposomes. The authors 
imagine that more hydrophobic TMDs might aggregate in the cytoplasm as 
they are released from ribosomes, creating an unsuitable conformation for ER 
insertion. In vivo, however, chaperones might prevent this aggregation.
Based on its low TMD hydrophobicity, the authors identifi  ed the PTP1B 
phosphatase as another self-inserting protein. Unassisted insertion only 
works in low-cholesterol membranes, such as the ER and mitochondria, 
whose lipids are free to move around while proteins push through. The Golgi 
and plasma membrane, by contrast, are probably too rigid.
Damage stops bud growth
D
NA damage checkpoint pathways reach out of the nucleus to 
control cell morphology, according to Smolka et al. (page 743) 
and Enserink et al. (page 729).
In budding yeast, DNA replication occurs in conjunction with the 
formation of the bud, which will receive the new set of chromosomes. DNA 
damage and other stresses activate checkpoint pathways that stall replication 
forks and start repair. The new papers show that these pathways also stall 
bud growth to maintain the synchrony between replication and morphology.
Both groups found that mutants of the Rad53 checkpoint kinase 
continued to elongate their buds during replication stress, when wild-type 
cells stopped bud growth. Enserink et al. suggest that checkpoint pathways 
activate a Cdk1-dependent switch, which turns off polar bud growth.
As buds grow, Cdk1 is normally inhibited by Swe1. But checkpoint 
activation caused Swe1 degradation and thus Cdk1 activation. Checkpoint 
mutants, however, were unable to degrade Swe1. They maintained 
bud-localized growth machinery and a polarized actin network.
Swe1 degradation depends on its localization to septins at the bud 
neck, where it is phosphorylated. Swe1 localization was normal in check-
point kinase mutants. 
Smolka et al. found, 
however, that Rad53 
binds to septins at the 
bud neck and phos-
phorylates septins in 
vitro. Perhaps this 
modiﬁ  cation is a pre-
requisite to Swe1 
phosphorylation.
Dumping of MVB cargo (green) into the vacuole 
(red) fails in mutants (right) that cannot 
oligomerize ESCRT-I.
Checkpoint mutants (right) are abnormally shaped.